November 5th, 2020 | 11:17 CET
NanoRepro, Osino Resources, Alibaba - Rich with special situations!
The election outcome for the old or new President of the United States of America is taking longer than anticipated. The back and forth caused the first dip in the world stock markets yesterday until they hiked back into the green zone. The overall situation, whether Trump or Biden, hadn't changed. You can currently see a similar trend for individual stocks. After shifts or delays, stocks fall like stones, offering investors the chance of disproportionate price gains.
time to read: 2 minutes
|
Author:
Stefan Feulner
ISIN:
CA68828L1004 , DE0006577109 , US01609W1027
Table of contents:
Author
Stefan Feulner
The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.
Tag cloud
Shares cloud
Better late than never!
For years, the shares of the rapid diagnostics manufacturer NanoRepro, based in Marburg an der Lahn, were bobbing along. The Company is one of the innovation leaders in the field of self-diagnostics and currently has 25 rapid tests in its portfolio - including an HIV test, two pregnancy tests and five more, purely for medical use. Then came Corona!
Size is an advantage
Thanks to its lean corporate structure, NanoRepro was able to react quickly and launched its first Corona antigen test at the end of September, which contributed a small six-figure sum to sales. However, the Company gave the go-ahead just under four weeks later. The test was approved by the Federal Institute for Drugs and Medical Devices (BfArM) as an antigen test for the direct detection of the coronavirus SARS-CoV-2.
Sales explosion leads to a re-evaluation
In 2019, the Marburg Company achieved an annual turnover of EUR 1,218,300. In comparison, the antigen test in the last two weeks of October brought in a volume of EUR 6 million. To satisfy the demand, NanoRepro offers three antigen tests from different suppliers, two of which are recognized by the Federal Institute for Drugs and Medical Devices (BfArM) and approved according to §1 Section 1 Clause 1 of the Coronavirus Test Regulation. The recognition of the third is to follow soon. We assume that the pandemic will not disappear overnight, and the strong demand for corona tests is likely to last even longer. A coup for NanoRepro!
Outstanding projects
The Namibian gold explorer Osino Resources has already scored a coup with its flagship project, Twin Hills Central. The area, which lies southwest of Otjikoto, has been defined so far with a length of 1.3 km. A first resource estimate is to be made here in early 2021.
Discovery well above expectations
The discovery drilling at Twin Hills at a depth of 65 metres and a gold grade of 1.37 grams per tonne, was so promising that the strip length has increased ten times. Several new targets have been defined along with the now 11-kilometre long gold system.
Analysts go on purchase
The analysts of the asset manager Echelon Capital Markets are bullish about the Company. For the Canadians, the Osino Resources share is a "top pick" for the fourth quarter of 2020 and thus a speculative buy. According to financial experts, the fair value of the Company is between CAD 2.30 and CAD 2.45. With a current share price of CAD 1.23, there is a chance that the share price will double.
Postponed is not cancelled
It was to be the largest IPO ever. Fintech heavyweight Ant Group wanted to raise USD 35 billion with the planned listing at a valuation of USD 200 billion, but the Shanghai Stock Exchange said "no". The group, which originated from the payment service Alipay, in which Alibaba still has a stake of about one third, would fail to meet the disclosure requirements due to changes in regulations, according to the stock exchange supervisory authority.
Delay triggers share price collapse
On Tuesday, Jack Ma, CEO of the parent Company Alibaba, was summoned to inform him about the temporary shutdown. After this announcement, Alibaba's shares fell by over 15% to 240 EUR from a high of 270 EUR. Of course, this decision is not final, and it would not be Jack Ma if there weren't a solution to every problem. The goal is undoubtedly to get rid of the 30% share package in the Ant Group.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.
Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.
Risk notice
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.
The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.
